Maitreya Medicare Other Announcement
Maitreya Medicare Limited confirms there is no deviation in the utilization of IPO proceeds for the half year ended September 30, 2026.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
13 announcements with these filters
Maitreya Medicare Limited confirms there is no deviation in the utilization of IPO proceeds for the half year ended September 30, 2026.
Maitreya Medicare Ltd reported revenue from operations of ₹23.7 Cr (+0.0% YoY) and a net loss of ₹0.9 Cr for H1 FY27.
Maitreya Medicare Limited has filed a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Maitreya Medicare Limited has announced the resignation of Ms. Kashish Surana from the position of Company Secretary and Compliance Officer, effective October 01, 2026.
Maitreya Medicare Limited held its 07th Annual General Meeting on September 21, 2026. The meeting discussed the adoption of financial statements and a director's re-appointment.
Maitreya Medicare Limited approved the scheduling of its 7th Annual General Meeting for September 21, 2026. The board also approved the Director's report and appointed a scrutinizer.
Maitreya Medicare Limited reported zero deviation in the utilization of its ₹14.89 Crore IPO proceeds. Funds were deployed toward subsidiary investments, debt redemption, and working capital.
Maitreya Medicare Limited re-appointed JDM and Associates LLP as Secretarial Auditors for FY 2026-27. This move ensures continued regulatory compliance and statutory oversight.
Maitreya Medicare appointed R P V & Company as Internal Auditor and re-appointed JDM and Associates as Secretarial Auditor. Both appointments carry 12-month terms.
Maitreya Medicare Ltd reported revenue from operations of ₹21.2 Cr (-4.9% YoY) and a net loss of ₹2.4 Cr for H2 FY26.
Maitreya Medicare Limited approved its audited standalone and consolidated financial results for the year ended March 31, 2026. The Board also approved auditor re-appointments and preference share redemptions.
Dr. Pranav Rohitbhai Thaker resigned as Whole-time Director and Founder effective May 25, 2026. He cited personal and professional commitments for his departure.
Maitreya Medicare scheduled a board meeting for May 29, 2026, to approve audited annual financial results. Trading window remains closed until June 1, 2026.